News

News
In the media

Johnson & Johnson: The Leading Healthcare Group at the Forefront of Open Innovation

Read full story
Partner news

Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development

Read full story
In the media

Michael Hübner – New Venture Lead, Johnson & Johnson Innovation Switzerland

Read full story
Partner news

Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test

Read full story
Partner news

Cue Health Closes $100 Million Series C Financing to Support Launch of Rapid Molecular Testing Platform

Read full story
In the media

BIO: Is COVID-19 changing how biopharmas think of M&A? Not really, say J&J and Takeda execs

Read full story
In the media

As Biotech drifts from amyloid hypothesis for Alzheimer’s some see reason to cling on

Read full story
Partner news

HistoSonics Announces $40 Million Financing

Read full story
Partner news

Imec collaborates with Janssen to advance precision medicine to treat and eliminate disease

Read full story
In the media

Ethics should be a compulsory course for every science student

Read full story
In the media

Women Who Tech Launches Health Innovation Challenge

Read full story
Partner news

DayTwo Secures $31 Million In Series B Financing To Scale Microbiome Research Platform To Address Chronic Health Conditions

Read full story
JNJ Press releases

Janssen Announces Collaboration with UC Berkeley, UCSF to Expand Data Science Research in Healthcare

Read full story
Partner news

Medicines Discovery Catapult, MQ: Transforming mental health and Alzheimer’s Research UK announce an innovative drug discovery consortium with industry, supported by the Wellcome Trust.

Read full story
Partner news

Navitor Pharmaceuticals Initiates a Clinical Study of NV-5138, a Novel, Oral Small Molecule for Treatment-Resistant Depression

Read full story